Journal of Plant Biochemistry & Physiology

Journal of Plant Biochemistry & Physiology
Open Access

ISSN: 2329-9029

+44 1478 350008

Research Article - (2016) Volume 4, Issue 1

Anti-Diabetic Activity of Dracaen cinnabari Balf.f Extracts from Resin in Socotra Island-Yemen

Yasser Hussein Eissa Mohammed and Shaukath Ara Khanum*
Department of Chemistry, Yuvaraja’s College, Mysore, Karnataka, India
*Corresponding Author: Dr. Shaukath Ara Khanum, Associate Professor, Department of Chemistry, Yuvaraja’s College, Mysore, Karnataka, India, Tel: +919901888755 Email:

Abstract

In the developing countries, the medical plants play an important role in treatment diabetes mellitus. This significant comes due to their cost effectiveness. Diabetes mellitus, a metabolic disorder is becoming a serious threat to mankind health. The herbal drugs with anti-diabetic activity are till now to be commercially formulated as modern medicines, even though they have been acclaimed for their therapeutic properties in the traditional systems of medicine. In this paper, we have reported a study based on anti-diabetic properties of Dragon cinnabari resin. The resin of plant material was collected, shade dried and extracted with different solvents using soxhlet extraction procedure. In vitro anti diabetic activity is assayed with standard glucose uptake procedure against MCF-7 cell line. From the analysis it was found that, glucose uptake inducing activity of ethyl acetate extract was found to be higher than Metformin, whereas other extracts did not display much anti diabetic activity against MCF-7 breast cancer cell line. Based on the glucose uptake studies against MCF-7 cell line, the ethyl acetate extract could be used as potential source for anti-diabetic drugs.

Keywords: Anti diabetic activity; Dragon cinnabari Blaf.f; Glucose uptake; Plant extract

Introduction

There are various medicines derived from plant extracts are being used in the treatment of a wide variety of clinical diseases, though relatively little knowledge about their mechanisms of action is known [1]. Many herbal preparations are being prescribed widely for the treatment of diabetic conditions. There is a need for research and developmental work in herbal medicine because apart from the social and economic benefits, it has become a persistent aspect of present day healthcare in developing countries [2,3]. Dragon’s blood tree is a nonspecific name for dark red resinous exudations from different plant species endemic to various regions around globe that belongs to four genera Dracaena Spp [4]. (Agavaceae), Croton Spp. (Euphorbiaceae), Daemonorops Spp. (Palmaceae) and Pterocarpus Spp. (Fabaceae) have a long history of being used as a traditional medicine the world over. Medicinal use of dragon’s blood dates back to the ancient Greeks, Romans, Chinese and Arabs [4-7]. However, Dracaena cinnabari Balf. f. (D. cinnabari) belongs to Agavaceae family, which is commonly known as Damm Al- akhwain in Yemen (Figure 1). It is endemic to the Socotra Island, Yemen. D. cinnabari resin has traditionally been used to treat diarrhea, wounds, fevers, ulcers, hemorrhage, control bleeding, fractures, and burns [5,7]. The Dragon’s blood tree has a wide application in biological area as antimicrobial, antioxidant, antidiarrhea and cytotoxicity effect [7-11]. Diabetes mellitus is dispersion in an alarming way throughout the world and three fourth of the world populations and careful as a major cause of high economic loss which can in turn impede the development of nations. Moreover, uncontrolled diabetes leads to many chronic complications such as blindness, heart disease, and renal failure [12]. Therefore, treating diabetes mellitus with plant derived compounds which are accessible and do not require laborious pharmaceutical synthesis appears highly attractive [4,12]. Although, Dragon’s blood tree is extensively used, little research has been done to know about its true source, quality control, bioactive compounds and clinical applications. Therefore, it is of a great interest to carry out a screening of these plant parts in order to validate their use in folk medicine and to reveal the active principle by isolation and characterization of their constituents. The systematic screening of them may result in the discovery of novel active compounds [8,9,12]. However, no work has been reported on the anti-diabetes property of this plant. Keeping in view, the present study has been undertaken to investigate anti-diabetic activity of the different extracts of Dracaen cinnabari Balf.f against MCF-7 cells lines.

plant-biochemistry-physiology-Dragon-blood

Figure 1: Dragon’s blood tree (D. cinnabari Balf. f) in Socotra Island, Yemen.

Materials and Methods

Materials

Plant extracts, 2-NBDG, (2-(N-(7-nitrobenz-2-oxa-1, 3-diazol-4- yl) amino)-2-deoxyglucose)), a fluorescent deoxy glucose analogue, is used as a probe for the detection of glucose taken up by cultured cells. It is transported by both SGLTs and GLUTs and has allowed the study of the effects of drugs targeting glucose uptake and glycolysis. NBDG fluorescence typically displays excitation/emission maxima of ~465/540 nm and can be visualized using optical filters designed for fluorescein, plant extracts, 2-NBDG (Invitrogen: Cat no. 13195), MCF-7 cell lines (from NCCS Pune), DMEM- High Glucose (High Media), Fetal Bovine Serum (High media), Penicillin-streptomycin (High media) 6-7 well plates (Corning), Serological pipettes (Corning), Pipettes (Benchtop), Pipette tips (Thermo), Bio safety cabinet (Biobase), CO2 incubator (Healforce), Inverted microscope (Biolinx), Flow cytometer (BD FACS callibur), Heamocytometer.

(i) Medium control (medium without cells).

(ii) Negative control (medium with cells but without the experimental drug/compound).

(iii) Positive control (medium with cells treated with a known drug, Metformin; 5mM).

Methods

Collection of plant material: Dragon’s blood tree (D. cinnabari) resin was collected from Socotra Island (Yemen) On May 2014. It has a matchless and strange appearance, described as upturned, denselypacked crown having the shape of an umbrella (Figure 1).

Preparation of extracts: About 800 gm of dry powder of the resin of Dracaena cinnabar was taken in a soxhlet apparatus and subjected for sequential extraction of solvents from non-polar to polar end (hexane, benzene, diethyl ether, dichloromethane, chloroform, ethyl acetate, acetone, ethanol, methanol and water) the extract samples were kept at 4°C for further assays. All the extracts were subjected to glucose uptake assay.

Cell culture and in vitro: MCF-7 cells were cultured in DMEM HG (Himedia) in T-75 tissue culture flask (Corning) until they reached 70% confluency. The cells were then harvested and used for the evaluation of anti-diabetic activity of the plant extracts by glucose uptake assay [13,14].

Glucose uptake assay

Glucose acts as the main fuel for maximum cells in mammals and is principally important for the heart and brain, which use glucose as their sole source of energy. Carbohydrates are only absorbed in the form of the monosaccharide through glucose transporter (Glucose uptake cell-based assay kit: Cayman Chemical Catalog no. 600470).

Cultured cells in a 6-well plate at a density of 1 × 105 cells/2 ml and incubated them in a CO2 incubator overnight at 37°C, After 24 hours, the spent medium is aspirated and the cells are treated with experimental compounds, control them in 2 ml glucose-free culture medium containing 100 μM 2- NBDG and incubated the cells for 2 hours, At the end of the treatment, the medium is removed from all the wells and PBS is given wash. The PBS is removed and 200 μl trypsin is added. The wells are Incubated at 37°C for 3-4 minutes, 2 ml culture medium is added and harvested the cells directly into 12 × 75 mm tubes. The tubes are centrifuged for five minutes at 300 g × 25°C. Carefully the supernatant is an aspirated. Then, the cells are suspended in 0.5-1 ml of PBS. Mixed well to ensure separation of individual cells. The cells analyzed with a flow cytometer. The cells must be analyzed immediately. The cells taken up 2-NBDG displayed fluorescence with excitation and emission at 465 nm and 540 nm, respectively, they can be measured in the FL1 channel which is used to detect FITC [13].

Results

The exaction process starting from non-polar to polar are summarized in Table 1. The results obtained from the glucose uptake assay are as follows:

Solvent Hexane Benzene Diethyl ether Di-chloromethane Chloroform Ethyl acetate Acetone Ethanol Methanol Water Residue
Resin (gm) 20 33.5 60 14.8 88.8 120.5 85 55 90 20 200

Table 1: Shows the yield of phytochemicals in the solvent extracts of D. cinnabari resin.

1. Untreated (NBDG only) (Figure 2)

plant-biochemistry-physiology-untreated-sample

Figure 2: In the untreated sample low NBGD uptake was observed with only 57.81% of cells in the M1 population (increased NBDG fluorescence).

2. Positive control- Metformin 2.5mM (Figure 3)

plant-biochemistry-physiology-glucose-uptake

Figure 3: Metformin at 2.5mM concentration showed increased glucose uptake compared to the untreated cells with 90.88% of cells with increased NBDG fluorescence (M1 gate).

3. Ethyl acetate extracts (Figure 4)

plant-biochemistry-physiology-higher-glucose

Figure 4: The ethyl acetate extract at 100 μg/ml showed higher glucose uptake by the cells as compared to the positive control Metformin (2.5mM) with 98.86% of the cells with increased NBDG fluorescence intensity (M1 gate).

4. Hexane extracts (Figure 5)

plant-biochemistry-physiology-fluorescence-intensity

Figure 5: As compared to the positive control Metformin (2.5mM), The hexane extract at 100 μg/ml showed low glucose uptake by the cells with 23.14% of the cells with increased NBDG fluorescence intensity (M1 gate).

5. Chloroform extracts (Figure 6)

plant-biochemistry-physiology-control-Metformin

Figure 6: The chloroform extract at 100 μg/ml showed medium glucose uptake by the cells as compared to the positive control Metformin (2.5mM) with 55.09% of the cells with increased NBDG fluorescence intensity (M1 gate).

6. Dichloromethane (DCM) extracts (Figure 7)

plant-biochemistry-physiology-DCM-extract

Figure 7: The DCM extract at 100 μg/ml didn’t showed glucose uptake by the cells as compared to the positive control Metformin (2.5mM) with 1.19% of the cells with increased NBDG fluorescence intensity (M1 gate).

7. Acetone extracts (Figure 8)

plant-biochemistry-physiology-fluorescence

Figure 8: The acetone extract at 100 μg/ml didn’t show glucose uptake by the cells as compared to the positive control Metformin (2.5mM) with 1.01% of the cells with increased NBDG fluorescence intensity (M1 gate).

8. Benzene extracts (Figure 9)

plant-biochemistry-physiology-increased-NBDG

Figure 9: The Benzene extract at 100 μg/ml showed good glucose uptake by the cells but also killed most of the cells as compared to the positive control Metformin (2.5mM) with 1.01% of the cells with increased NBDG fluorescence intensity (M1 gate).

9. Ethanol extracts (Figure 10)

plant-biochemistry-physiology-methanol-extract

Figure 10: The ethyl acetate extract at 100 μg/ml showed high glucose uptake by the cells as compared to the positive control Metformin (2.5mM) with 74.17% of the cells with increased NBDG fluorescence intensity (M1 gate).

10. Methanol extracts (Figure 11)

plant-biochemistry-physiology-cells-compared

Figure 11: The methanol extract at 100 μg/ml showed good glucose uptake by the cells but also killed most of the cells as compared to the positive control Metformin (2.5mM) with 5.09% of the cells with increased NBDG fluorescence intensity M1 population (M1 gate).

11. Ether extracts (Figure 12)

plant-biochemistry-physiology-jasmonic-acid

Figure 12: The Ether extract at 100 μg/ml showed no glucose uptake by the cells and also killed most of the cells as compared to the positive control Metformin (2.5mM) with 7.69% of the cells with increased NBDG fluorescence intensity (M1 gate).

Discussion

Diabetes mellitus is spreading in a very fast way throughout the world. Blindness, heart disease, and renal failure are some chronic complications results of the uncontrolled diabetes. In a matter of fact, it seems attractive to treat with plant that doesn’t require more pharmaceutical synthesis. Glucose uptake inducing activity of ethyl acetate extract was found to be higher than Metformin with 98.86% which indicates that this extract can be used as a source of anti-diabetic drugs. Which is followed by benzene, ethanol and chloroform extract with 88.57%, 70%, 55.09% respectively and hexane extracts have shown moderate with 23% while diethyl ether, methanol, dichloromethane and acetone have not shown activity.

Conclusion

In this study, we have reported the antidiabetic properties of Dragon cinnabari resin. The resin of plant material was extracted with different solvents and evaluated for them in vitro antidiabetic activity with standard Glucose uptake procedure against MCF-7 cell line. From the results, the ethyl acetate extract was found to be higher glucose uptake inducing activity than Metformin, whereas other extracts did not display much anti-diabetic activity against MCF-7 cell line. Based on the glucose uptake studies against MCF-7 cell line, the ethyl acetate extract could be used as potential source for anti-diabetic drugs.

Acknowledgements

Yasser Eissa wish to acknowledge the financial assistance provide by University of Hajja, Yemen and Shaukath Ara Khanum gratefully acknowledged the financial support provided by the Vision Group on Science and Technology, Government of Karnataka, under the scheme CISEE (VGST/CISSE/2012-13/2882), Department of Information Technology, Biotechnology and Science and Technology, Bangalore, India.

References

  1. Ratheesh M, Helen A (2007) Anti-inflammatory activity of RutagraveolensLinn on carrageenan induced paw edema in wistar male rats. Afr J Biotechnol6:11-1209.
  2. Bagul MS, Srinivasa H, Kanaki NS, Rajani M (2005) Antiinflammatory activity of two Ayurvedic formulations containing guggulInd. J Pharm 37: 399-400.
  3. Mahabir D, Gulliford MC (1997) Use of medicinal plants for diabetes in Trinidad and Tobago. Rev PanamSaludPublica 1:174-179.
  4. Edward CC, Robert RH (2010) SGLT2 inhibition-a novel strategy for diabetes treatment. Nat Rev Drug Discov 9:551–559.
  5. Masaud M, Ripperger H, HimmelerichU, Adam G(1995)Cinnabaron, ABiflavonoid from Dragon’s Blood of Dracaena Cinnabari, Institute of plant. Phytochemistry 38:751-753.
  6. Mothana R, Mentel R, Reiss C, Lindequist U(2006) Phytochemical screening and antiviral activity of some medicinal plants from the island Socotra. Phytother Res 20: 298-302.
  7. Yehia AA, Alzowahi FA, Kadam TA, Shaikh RU (2013) In vitro evaluation of antimicrobial and antioxidant activity of Dragon’sblood tree (Dracaena cinnabariBalf.f.) of Socotra Island (Yemen). Journal of Coastal Life Medicine 1: 123-129.
  8. Ponnusamy S, Ravindran R, Zinjarde S, Bhargava S, Kumar AR (2011) Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evid Based Complement Alternat Med, A ID: 51564. 2011: 1-10.
  9. Mahabir D, Gulliford MC (1997) Use of Medicinal plants for diabetes in Trinidad. pp:174-179.
  10. Alwashli A, Al-Sobarry M, Cherrah Y, Alaoui K (2012) Anti-inflammatory and analgestic effect of ethanol extract of dracaena cinnabaribalf, as endemic plant in Yemen. International Journal of Pharma and Bio Sciences3:96-106.
  11. Masaoud M, Himmelrich H, Ripperger B, Adam G (1995) New bioflavonoid from Dracaena Cinnabari. Plant Medica 61: 341-344.
  12. Grover JK, Yadav S, Vats V (2002)Medicinal plants of India with anti- diabetic potential. J Ethnopharmacol81:81-100.
  13. Tsay HS, Agrawal DC (2005)Tissue Culture Technology of Chinese Medicinal Plant Resources in Taiwan and their Sustainable Utilization. Int J AppSciEng 3:215223.
  14. Ranganath VL, Avin BR, Thirusangu P, Prashanth T, Prabhakar BT, et al. (2013) Synthesis, angiopreventive activity, and in vivo tumor inhibition of novel benzophenone–benzimidazole analogs.Life Sci 93: 904-911.
Citation: Mohammed YHE, Khanum SA (2016) Anti-Diabetic Activity of Dracaen cinnabari Balf.f Extracts from Resin in Socotra Island-Yemen. J Plant Biochem Physiol 4:162.

Copyright: © 2016 Mohammed YHE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top